Brain electrical activity mapping for diagnosing psychiatric disorders: a review of the clinical evidence
Canadian Agency for Drugs and Technologies in Health (CADTH)
Record ID 32015000825
English
Authors' recommendations:
Parameters of quantitative electroencephalograh (qEEG) such as the theta index, alpha index, and the absolute powers derived from the frequency bands in EEG do not possess sufficient diagnostic ability to individually distingush between Alzheimer's Disease AD patients and healthy control patients. However, a combination of the left hemisphere alpha/theta index of the qEEG and Mini-Mental State EXamination (MMSE) achieved improved diagnostic accuracy for AD compared with MMSE alone. Quantitative EEG methods demonstrated poor diagnostic ability for AD in a selected group of patients with various degrees of dementia conditions.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
https://www.cadth.ca/brain-electrical-activity-mapping-diagnosing-psychiatric-disorders-review-clinical-evidence
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Acetylcholine
- Bipolar Disorder
- Brain Mapping
- Dementia
- Dopamine
- Schizophrenia
- Serotonin
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.